New specialist referral centre to open

Nov 20, 2017

A state-of-the-art, multi-million pound referral centre for specialist surgical and neurological referrals is set to open in Buckinghamshire early in 2018. Michael Hamilton. Hamilton Specialist Referrals will be a wholly independent business and will be the only one of its kind in the local area when it opens in High Wycombe in February. The hospital will be open 24 hours a day, 365 days a year, and will offer the most advanced treatment options available for orthopaedic, neurosurgical and neurological cases. Facilities will include on-site 1.5T MRI and CT scanner suites, a variety of joint replacement systems, electrodiagnostics and a full complement of the latest radiography and arthroscopy equipment. The hospital will have a dedicated physiotherapy and rehabilitation department, which will include aqua treadmills and computerised gait analysis technology. Founder and specialist surgeon Michael Hamilton said: “We have invested heavily in some of the very best equipment, and we are in talks with some of the most talented and dedicated clinicians and nurses in the industry. Hamilton Specialist Referrals will... ...

Read More

FVE appeals to protect vets’ working rights in Brexit talks

Nov 20, 2017

The organisation representing vets across Europe has issued a plea to the Government to secure the working rights of EU and UK vets during Brexit negotiations. The Federation of Veterinarians of Europe (FVE) represents veterinary organisations from 38 EU and non-EU countries, including the UK. It also counts the BVA and RCVS – which helped develop the plea – among its members. Issued ahead of the next round of deliberations in Brussels, the FVE document said Brexit negotiators must not jeopardise the high levels of animal health and welfare, public health and environmental protection enjoyed across Europe. It also highlighted the “vital” role the profession plays in animal health and welfare, antimicrobial resistance and food safety. BVA senior vice-president Gudrun Ravetz said: “We are united with colleagues across Europe in our call to secure working rights for UK and EU vets in the Brexit negotiations. The varied and diverse roles in the veterinary profession provide the foundation for high animal health and welfare, and make essential contributions to the economy... ...

Read More

InGeneron ARC system hits UK market

Nov 20, 2017

UK vets will soon have access to a piece of kit for the treatment of a range of orthopaedic injuries, allergies and non-healing wounds in dogs and horses. Nupsala Veterinary Services has signed an exclusive license and agreement with InGeneron to supply the point of care ARC system to the UK veterinary market. InGeneron’s ARC system allows veterinary clinics to rapidly prepare canine and equine adipose-derived regenerative cells and platelet-rich plasma (PRP) from an animal’s own body at point of care for immediate treatment for a range of diseases and injuries. Vets can use prepared cells to aid the treatment of orthopaedic injuries, OA, allergies and non-healing wounds in dogs and horses, Nupsala said. A company spokeman said: “InGeneron’s ARC tissue processing system uses fat tissue obtained from the patient. Regenerative cells, including stem cells, are prepared for reinjection in about 90 minutes from excised solid tissue, or 60 minutes for lipoaspirate. “With the ability to process solid tissue in practice, this point of care system offers a new and... ...

Read More

Pimobendan study outcome – a ‘revolution’ for vet cardiology

Nov 13, 2017

A product that delays onset of congestive heart failure (CHF) in dogs by 15 months offers a “paradigm shift” in the way vets diagnose and treat myxomatous mitral valve disease (MMVD). Boehringer Ingelheim, the company behind pimobendan drug Vetmedin, cautiously estimated 7.5% of all dogs would suffer heart disease in their lifetimes, with MMVD its most prevalent form. Vetmedin was already licensed for the treatment of canine CHF from dilated cardiomyopathy or valvular insufficiency, as well as for treatment of cardiomyopathy in the preclinical stage in Dobermann pinschers. However, following the largest clinical trial in veterinary cardiology, the product can now be used by vets to treat the preclinical stage of MMVD, delaying onset of the clinical symptoms of heart failure. At an official launch for the European veterinary press, held in Frankfurt and attended by Veterinary Times, it was noted up to 40 million dogs worldwide could now benefit with treatment from pimobendan. The evaluation of pimobendan in dogs with cardiomegaly (EPIC) study set out to analyse whether long-term... ...

Read More

Veterinary/Animal Vaccines Market to Grow at 5.9% CAGR to 2022 Led by Europe – ReportsnReports

Nov 13, 2017

Veterinary/Animal Vaccines Market Size will reach $8.66 billion by 2022 from $6.50 billion in 2017 at a CAGR of 5.9% between (2017-2022) driven by the growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. The key players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France). Other notable players operating in this market include Vetoquinol (France), Hester (India), Hipra (Spain), IDT Biologika (Germany), China Animal Husbandry (China), Biogenesis Bago (Argentina), Tianjin Ringpu (China), and Jinyu Bio-technology (China). Geographically, Europe is the largest market for veterinary vaccines market, followed by North America but the APAC region is expected to witness the highest growth in the forecast period. This growth is primarily attributed to rising pet adoption, expansion of key vaccine players in... ...

Read More

Controlled and consistent printing for veterinary practices

Nov 10, 2017

ScriptX, from UK company MeadCo, provides controlled, consistent and efficient printing from Internet Explorer. Essential for veterinary practices, ScriptX enables labels, barcodes, permission slips, claim forms, prescriptions, and more to be printed in a controlled format, from every networked Windows computer. In use across the globe, ScriptX is helping to increase efficiency and reduce costs by enabling the precise control of printing of browser-hosted content on Microsoft Windows. Veterinary practices are using ScriptX to improve procedures in several key areas: Faster, automated printing of identification details and barcoded labels to improve clinic efficiency, speeding up admissions and management of supplies Printing of vital permission and claims forms in the right format at the right location so that they can be processed accurately and rapidly Production of instant copies of animal medical records to aid diagnosis and care Creation of identification badges for staff and visitors Faster printing without the need to cancel or complete pop-up print dialogue boxes Automatic return to individual print settings as soon as a specific print... ...

Read More